Ocular Biomarkers of Riboflavin Transporter Deficiency
Authors:
- Emma C. BedoukianEBEmma C. Bedoukian
- Erin C. O'NEilEOErin C. O'NEil
- Ian D. KrantzIKIan D. Krantz
- Sabrina W. YumSYSabrina W. Yum
- Grant T. LiuGLGrant T. Liu
- Tomas S. AlemanTATomas S. Aleman
- 2 August 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 43 (1) , 110-115
Abstract
Background: To describe the clinical presentation with a focus on ocular manifestations and response to riboflavin supplementation of 3 patients with riboflavin transporter deficiency (RTD) caused by mutations in SLC52A2 ( SLC52A2- RTD). Methods: This is a retrospective review of records of 3 children (aged 18, n = 2 and age = 8, n = 1) with SLC52A2- RTD. Patients underwent comprehensive ophthalmic evaluations including color vision testing, pattern visual-evoked potentials (pVEPs, 1 patient) and spectral domain optical coherence tomography (SD-OCT) imaging. Patients received riboflavin supplements from the time of the molecular diagnosis of RTD. Results: Two unrelated 18-year-old patients with SLC52A2- RTD had a symptomatic onset with sensorineural hearing loss and auditory neuropathy/dys-synchrony since age 3 and 11, respectively. On examination 7 years after symptomatic onset, they showed subnormal visual acuities (20/30 and 20/60, both eyes, respectively), preserved color vision, and a thin but measurable retinal ganglion cell layer (GCL) and nerve fiber (RNFL). The inner and outer nuclear layers were normal. The asymptomatic SLC52A2- positive brother of one of these patients started riboflavin supplementation right after the molecular diagnosis and had normal vision and SD-OCTs 7 years later. Onset of riboflavin supplementation in one of the 2 symptomatic cases resulted in acute improvement of the pattern visual-evoked potential and vision. Conclusions: Retinal ganglion cells and their axons are uniquely susceptible to RTD compared with other highly energy-dependent retinal neurons, such as photoreceptors, raising the possibility for alternative mechanisms of disease or protection. Riboflavin supplementation results in acute functional improvement of vision and long-term preservation of GCL and RNFL if initiated early.Keywords
This publication has 23 references indexed in Scilit:
- 1q21.1 Microduplication expression in adultsGenetics in Medicine, 2013
- Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown‐Vialetto‐Van Laere syndromeJournal of Inherited Metabolic Disease, 2012
- Validation of the Charcot–Marie–Tooth disease pediatric scale as an outcome measure of disabilityAnnals of Neurology, 2012
- The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectivesOrphanet Journal of Rare Diseases, 2012
- Early use of high‐dose riboflavin in a case of Brown–Vialetto–Van Laere syndromeDevelopmental Medicine & Child Neurology, 2011
- Energy metabolism of the visual systemEye and Brain, 2010
- Brown-Vialetto-Van Laere Syndrome, a Ponto-Bulbar Palsy with Deafness, Is Caused by Mutations in C20orf54The American Journal of Human Genetics, 2010
- How disturbed visual processing early in life leads to disorders of gaze-holding and smooth pursuit2008
- Brown–Vialetto–Van Laere syndrome; variability in age at onset and disease progression highlighting the phenotypic overlap with Fazio-Londe diseaseBrain and Development, 2005
- Contribution to the Ocular Manifestation of Riboflavin DeficiencyThe Tohoku Journal of Experimental Medicine, 1954